Top 5 blog posts by Dr. Henry Rosevear
Blog posts from Henry Rosevear, MD, continue to be among Urology Times’ most popular content online. A urologist in community practice in Colorado Springs, CO and member of the Urology Times Clinical Practice Board, Dr. Rosevear was recognized in 2016 by the American Society of Healthcare Publication Editors with a “Gold” award for best blog. Here were his most-read posts of 2016:
AUA 2016: Reflections on mentors, MRI fusion, and more
Dr. Rosevear’s takeaways from the 2016 annual meeting also included observations regarding PSA screening, urethral mesh sling, and more. Read more
An insurer’s $4.07 check: A sign of the times
For managing a patient with an obstructing stone, Dr. Rosevear’s group billed $1,332.25 for his services. The check from the Colorado Indigent Care Program (CICP), the patient’s insurer, was for $4.07. “A single-payer system (such as CICP) is nothing more than nationalization of health care providers’ time, effort, and skills,” he writes. Read more
Read comments on this post.
Marijuana and me: One urologist’s experience
Dr. Rosevear practices medicine in Colorado, where the state’s ongoing experiment with legal recreational marijuana has provided him a significant amount of professional experience with the drug. Its impact on urology is wide ranging, he says, affecting areas as diverse as fertility and anesthesia. Read more
The transgender community: Urology has a role and responsibility
"The fear of a hypothetical situation should not be used to place restrictions on the life of one of our transgender patients," writes Dr. Rosevear in this post, which generate several comments from readers. Read more
VA Choice: Not what the doctor ordered
Dr. Rosevear explains why his practice no longer participates in Veterans Choice-and what can be done to improve the program. Read more
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
Real-time patient access to charts opens up real potential for misinterpretations
January 29th 2021"I have no problem with patients seeing everything in their chart. It is their medical record, after all. But I do think there should be some limitations on this access," writes Henry Rosevear, MD.
The BCG shortage: No short-term solution!
April 25th 2019"Bacillus Calmette-Guerin (BCG) intravesical immunotherapy is the most effective treatment for management of our patients with non-muscle invasive bladder cancer. What do we do without it, and how do we explain the current worldwide BCG shortage to our patients?" writes Adele M. Caruso, DNP, CRNP.
Residency vs. the real world: 5 things I wish I’d known
April 2nd 2019"Just like I’ve learned that the grass really isn’t any greener on the other side, I am learning that life in the trenches of urology, as a small-town urologist, isn't exactly what I thought it would be when I was a resident," writes Dr. Rosevear.
